FindTrial
Sign In

A Worldwide Registry of Patients with Gall Bladder Cancer

Global Gall Bladder Cancer Registry to collate data on epidemiology, treatment patterns and outcomes - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100312
Enrollment
5000
Registered
2026-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K828- Other specified diseases of gallbladder

Interventions

Intervention1: Nil: Nil Control Intervention1: NIL: NIL

Sponsors

International Hepatopancreatobiliary Association in collaboration with Radboudumc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with a diagnosis of gallbladder cancers

Exclusion criteria

Exclusion criteria: Patients with other biliary tract cancers Patients found to have non-malignant pathology on final histopathology report

Design outcomes

Primary

MeasureTime frame
1.Register prevalent cases within a defined time period (diagnosed from 1st Jan 2016 to 30th September 2025) 2.Collect demographic data 3.Collect surgical data and outcomes (where appropriate) 4.Collect non-surgical treatment data Describe clinical outcomes according to region, demographics and treatment Timepoint: 5 years—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India, Netherlands

Contacts

Public ContactDr Mahesh Goel

Tata Memorial Hospital

drshraddhapatkar@gmail.com9820074818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026